Which statement correctly describes the use of cryoprecipitate in DIC?

Which statement correctly describes the use of cryoprecipitate in DIC?

• A. Cryoprecipitate is indicated for DIC
• B. Cryoprecipitate is contraindicated in DIC
• C. Cryoprecipitate replaces platelets only
• D. Cryoprecipitate dissolves clots instantly

Answer: (A)

In DIC, clotting factors and fibrinogen are consumed, leading to bleeding. Cryoprecipitate is used to replace fibrinogen (and some related factors) when levels are low, which helps restore the ability to form proper clots at sites of bleeding. This makes cryoprecipitate indicated in DIC specifically when there is hypofibrinogenemia contributing to hemorrhage. It’s not a platelet substitute, so it doesn’t replace platelets or increase platelet counts. It also doesn’t dissolve clots; rather, it provides components that help clot formation when fibrinogen is deficient. In managing DIC, the overall approach includes addressing the underlying cause and giving targeted transfusions such as platelets for thrombocytopenia, fresh frozen plasma for broad factor replacement, and cryoprecipitate when fibrinogen is low and bleeding persists.

In DIC, clotting factors and fibrinogen are consumed, leading to bleeding. Cryoprecipitate is used to replace fibrinogen (and some related factors) when levels are low, which helps restore the ability to form proper clots at sites of bleeding. This makes cryoprecipitate indicated in DIC specifically when there is hypofibrinogenemia contributing to hemorrhage.

It’s not a platelet substitute, so it doesn’t replace platelets or increase platelet counts. It also doesn’t dissolve clots; rather, it provides components that help clot formation when fibrinogen is deficient. In managing DIC, the overall approach includes addressing the underlying cause and giving targeted transfusions such as platelets for thrombocytopenia, fresh frozen plasma for broad factor replacement, and cryoprecipitate when fibrinogen is low and bleeding persists.